Attached files
file | filename |
---|---|
10-Q/A - NANOVIRICIDES 10-Q A 12-31-2009 - NANOVIRICIDES, INC. | form10qa.htm |
EX-3.1 - EXHIBIT 3.1 - NANOVIRICIDES, INC. | ex3_1.htm |
EX-4.1 - EXHIBIT 4.1 - NANOVIRICIDES, INC. | ex4_1.htm |
EX-10.1 - EXHIBIT 10.1 - NANOVIRICIDES, INC. | ex10_1.htm |
EX-31.1 - EXHIBIT 31.1 - NANOVIRICIDES, INC. | ex31_1.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. §1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report on Form 10-Q (the “Report”) of
NanoViricides, Inc. (the “Company”) for the quarter ended December 31, 2009,
each of the undersigned Eugene Seymour, the Chief Executive Officer of the
Company, and, the Chief Financial Officer of the Company, hereby certifies
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to the best of the undersigned’s knowledge and
belief:
|
(1)
|
the
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
(2)
|
the
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
Dated:
February 22, 2010
|
/s/ Eugene Seymour
|
Eugene
Seymour
|
|
Chief
Executive Officer and Interim
|
|
Chief
Financial Officer
|
|
|
(Principal
Executive and Financial
Officer)
|